Hypoxia and inflammation [3]

New England Journal of Medicine

Volumn 364, Issue 20, 2011, Pages 1976-1977

  Wanderer, Alan A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; HYPOXIA INDUCIBLE FACTOR; INFLAMMASOME; INTERLEUKIN 1BETA; NIFEDIPINE;

AUTOSOMAL INFLAMMATORY SYNDROME; CINCA SYNDROME; CYTOKINE RELEASE; DRUG TARGETING; HOMEOSTASIS; HYPOXIA; INFLAMMATION; LETTER; NEUTROPHIL; PRIORITY JOURNAL; REPERFUSION INJURY; SYNDROME; ALTITUDE DISEASE; ANIMAL; ANOXIA; DISEASE MODEL; HEMODYNAMICS; HUMAN; MOUSE; NOTE; PULMONARY HYPERTENSION; DISEASE ASSOCIATION; EXTRAVASATION; HYPOXIC LUNG VASOCONSTRICTION; LUNG EDEMA;

ALTITUDE SICKNESS; ANIMALS; ANOXIA; DISEASE MODELS, ANIMAL; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION; MICE;

EID: 79956225996     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1103019     Document Type: Letter

References (4)

1. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011;364:656-65.
2. Wanderer AA. Ischemia-reperfusion syndrome: biochemical and immunologic rationale for IL-1 targeted therapy. Clin Immunol 2008;128:127-32.
3. Hoffman HM, Wanderer AA. Inflammasome and IL-1 beta mediated disorders. Curr Allergy Asthma Rep 2010;10:229-35.
4. Iyer SS, Pulskens WP, Sadler JJ, et al. Necrotic cells trigger a sterile inflammatory response through the NLRP-3 inflammasome. Proc Natl Acad Sci U S A 2009;106:20388-93.